But the news led me to reflect on his achievements and I was left with a couple of questions - what is value? And what has the quality improvement movement achieved to increase it?
To take the second question first. Robert H Brook announced in his article in JAMA the end of the quality improvement movement
"more than 40 years after the birth of the quality improvement movement, there is still not much known about what has been accomplished. There is little information about whether quality is better in one state or country than another; what the relationship is between the amount a country spends on health care and the quality of care provided in its health care system; whether a business case for quality actually exists in an individual institution or physician’s office; and whether the amount of money spent on improving quality is too little or too much".
It's a provocative statement. 40 years of quality improvement and we don't know if it has made any difference? His prescription? Focus on value.
So what is value? Well Brook, Porter, Gray and others would say that the value equation goes something like this:
It sounds very plausible doesn't it. After all, who wouldn't want to know where you can get the biggest bang for your buck from. And in the current lingua franca all these elements make a great deal of sense. But is there anything wrong with the equation? Does it really describe value?
My biggest concern about this value equation is that it does not describe value, at least from a users point of view, at all. For in this equation value is increased when costs go down. I don't agree. It seems to me this is an "inside out" view which describes value for money, not value. And this is important because this colours our perception of what good looks like and implicitly and invisibly restricts our ability to transform services rather than polish them.
Taking improved outcomes, undeniably if you can stop people cutting off the wrong limb, that has to be better for patients. Personally, I would value that. But in terms of how people experience illness, it seems to me that judging outcomes is a devilishly difficult thing to do.
Take the following scenarios. Scenario one; a woman in her early 50's is diagnosed with a rare and aggressive cancer. The medical profession can do things to prolong the womans life and she undertakes four courses of chemotherapy, the gaps between each course being extended every time to allow the burns on her mouth to heal and for her to recover her strength as she finds the treatment incredibly debilitating. So much so that she spends much of her time in bed and has little energy or inclination to play with her grandchildren or socialise with friends and family. Increasingly dependent on others for support with even the most basic of daily living needs eventually she is admitted to hospital where she is sent to ITU, intubated and, after nearly two weeks, passes away having drifted in and out of consciousness during that time, but largely unconscious.
The family are grief stricken. They had so wanted her to survive long enough to see her youngest son marry. There was also some guilt and recriminations over the last few months of her life, with some wishing she had never been put through the ordeal, others wondering if enough had been done. But her life had been extended so, from that perspective, the tens of thousands of pounds spent on treatment were worth it, weren't they? Value, in terms of improved outcome as measured by extended life or survival rate has been increased.
Scenario two; the same woman, agrees to undergo a course of chemotherapy. She doesn't get on with it very well but feels a sense of obligation to continue. She wants to live after all. Well, at least long enough to see her youngest son marry in 6 months time, she tells her oncologist. That chance remark sparks a conversation in which the truth of her diagnosis is honestly discussed. It becomes clear that the woman fears the treatment at least as much as the cancer, which she knows is going to kill her anyway. The family, until then apparently equally supportive of extending her life, helping her to survive, also air their concerns about whether this is the best course of action.
The resolution? The wedding is brought forward and the chemo stopped. The inevitable decline is managed palliatively and the woman passes away, surrounded by loved ones, each of whom she has been able to say a few final cherished words to.
My question is, in terms of value, which scenario has created the greatest? And does the equation help us understand value in this context?
In the week that the Government announced that it was to make trial drugs available to patients a year early I was reminded of what Atul Gawande said in his excellent article in the New Yorker - "We've created a multi-trillion dollar edifice for dispensing the medical equivalent of lottery tickets - and have only the rudiments of a system to prepare patients for the near certianty that those tickets will not win. Hope is not a plan, but hope is our plan".
In applying the Vanguard Method in health I have been struck by how damaging the focus on costs is. I have seen how relationships and continuity over time have been broken and how, for vast numbers of people, this creates a flightpath to dependence and all the cost that goes along with that. I have seen medicine attempt to do too much when sometimes, as Gawande says, it needs to do less. And I have seen how this has created a quality improvement movement that has focussed it's attention on improving processes at the expense of understanding people in the context of how they live their life.
For me, there are many commentators who talk about the austerity of the current economic climate. This may be true, but my concern is that the answer lies not in cost reduction but in better understanding value from a users perspective. Then we may be able to support both users and carers in reaching the right decisions for themselves.
Footnote: out of interest I searched for the word "value" in the operating framework. It comes up 11 times in the 50 page document, 7 times related to value for money or financial value.
So what is value? Well Brook, Porter, Gray and others would say that the value equation goes something like this:
Value = Improved outcome/cost
It sounds very plausible doesn't it. After all, who wouldn't want to know where you can get the biggest bang for your buck from. And in the current lingua franca all these elements make a great deal of sense. But is there anything wrong with the equation? Does it really describe value?
My biggest concern about this value equation is that it does not describe value, at least from a users point of view, at all. For in this equation value is increased when costs go down. I don't agree. It seems to me this is an "inside out" view which describes value for money, not value. And this is important because this colours our perception of what good looks like and implicitly and invisibly restricts our ability to transform services rather than polish them.
Taking improved outcomes, undeniably if you can stop people cutting off the wrong limb, that has to be better for patients. Personally, I would value that. But in terms of how people experience illness, it seems to me that judging outcomes is a devilishly difficult thing to do.
Take the following scenarios. Scenario one; a woman in her early 50's is diagnosed with a rare and aggressive cancer. The medical profession can do things to prolong the womans life and she undertakes four courses of chemotherapy, the gaps between each course being extended every time to allow the burns on her mouth to heal and for her to recover her strength as she finds the treatment incredibly debilitating. So much so that she spends much of her time in bed and has little energy or inclination to play with her grandchildren or socialise with friends and family. Increasingly dependent on others for support with even the most basic of daily living needs eventually she is admitted to hospital where she is sent to ITU, intubated and, after nearly two weeks, passes away having drifted in and out of consciousness during that time, but largely unconscious.
The family are grief stricken. They had so wanted her to survive long enough to see her youngest son marry. There was also some guilt and recriminations over the last few months of her life, with some wishing she had never been put through the ordeal, others wondering if enough had been done. But her life had been extended so, from that perspective, the tens of thousands of pounds spent on treatment were worth it, weren't they? Value, in terms of improved outcome as measured by extended life or survival rate has been increased.
Scenario two; the same woman, agrees to undergo a course of chemotherapy. She doesn't get on with it very well but feels a sense of obligation to continue. She wants to live after all. Well, at least long enough to see her youngest son marry in 6 months time, she tells her oncologist. That chance remark sparks a conversation in which the truth of her diagnosis is honestly discussed. It becomes clear that the woman fears the treatment at least as much as the cancer, which she knows is going to kill her anyway. The family, until then apparently equally supportive of extending her life, helping her to survive, also air their concerns about whether this is the best course of action.
The resolution? The wedding is brought forward and the chemo stopped. The inevitable decline is managed palliatively and the woman passes away, surrounded by loved ones, each of whom she has been able to say a few final cherished words to.
My question is, in terms of value, which scenario has created the greatest? And does the equation help us understand value in this context?
In the week that the Government announced that it was to make trial drugs available to patients a year early I was reminded of what Atul Gawande said in his excellent article in the New Yorker - "We've created a multi-trillion dollar edifice for dispensing the medical equivalent of lottery tickets - and have only the rudiments of a system to prepare patients for the near certianty that those tickets will not win. Hope is not a plan, but hope is our plan".
In applying the Vanguard Method in health I have been struck by how damaging the focus on costs is. I have seen how relationships and continuity over time have been broken and how, for vast numbers of people, this creates a flightpath to dependence and all the cost that goes along with that. I have seen medicine attempt to do too much when sometimes, as Gawande says, it needs to do less. And I have seen how this has created a quality improvement movement that has focussed it's attention on improving processes at the expense of understanding people in the context of how they live their life.
For me, there are many commentators who talk about the austerity of the current economic climate. This may be true, but my concern is that the answer lies not in cost reduction but in better understanding value from a users perspective. Then we may be able to support both users and carers in reaching the right decisions for themselves.
Footnote: out of interest I searched for the word "value" in the operating framework. It comes up 11 times in the 50 page document, 7 times related to value for money or financial value.